Any current/future new fundraising through debt or equity?

The company has ongoing CAPEX plans with a remaining Rs. 1,500 crore to be spent in FY24. Peak net debt by March is expected to be in the range of Rs. 1,500 to Rs. 1,900 crore. No specific mention of new fundraising through equity or fresh debt in the disclosed content. Existing debt levels are comfortable with net debt at Rs. 681 crore as of 31st March 2023. Management is focusing on maintaining a strong financial position and exploring new avenues for growth, but no explicit plans for fundraising were detailed.

Any current/future capex/capital investment/strategic investment?

Total CAPEX program is Rs. 3,500 crore, with about Rs. 600 crore already commissioned (Rs. 530 crore in sugar, Rs. 60-70 crore in chemicals). Remaining Rs. 2,900 crore largely in chemicals to be commissioned over next two quarters (by end of Q2 FY24). 120 MW power plant project costing Rs. 500-550 crore expected to be commissioned by Q1 end FY24, providing annual savings of Rs. 100-125 crore. Rs. 530 crore sugar CAPEX already capitalized with expected ~20% return. Facilities and expansions in Fenesta (Bhuvneshwar, Hyderabad, Kota) ongoing to meet rising demand. New product lines and manufactur

Future growth expectations in sales/revenue/volumes?

Bioseed business: Expected to grow in FY24 at least at the same rate as FY23, driven by market-accepted products and a robust pipeline across all key crops (cotton, corn, paddy, vegetables). Long-term growth positive but dependent on competitive landscape yearly. (Pages 16-17) Ethanol production capacity expanding from 14 crore liters to 18 crore liters in the coming year, indicating higher sales volumes. (Pages 5, 10, 14) Fenesta Building Systems: Strong order book growth (~10-23%) and volume increases in projects and retail, indicating sustained revenue growth. (Pages 6-7) Chemicals busin

Future growth expectations in earnings/operating earnings/profits/EPS?

Bioseed business is expected to grow in FY24 at similar or better rates than FY23 due to accepted products and a strong pipeline across crops like cotton, corn, paddy, and vegetables. Long-term growth over the next 3-4 years is anticipated but subject to market competition. Chemicals segment margins are expected to improve gradually with declining input costs and completion of capacity expansions by Q2 FY24, though price volatility in epoxy and ECH may impact near-term spreads. Fertilizer segment sees improved energy efficiencies and subsidy reductions aiding profitability despite price co

Current/ Expected Orderbook/ Pending Orders?

Fenesta Building Systems' order book grew by 10% year-on-year. The project and retail categories both witnessed improvements in the order book. The demand scenario for Fenesta is stable, although competition is increasing. The company is expanding its core business, adding new categories and increasing geographic reach, including internationally. New products such as glass façades, UPVC and aluminum windows, WPC, and engineered wood doors are being launched. Two new factories commissioned (Bhuvneshwar and Hyderabad), with expansion underway at Kota. Overall, the order book reflects good moment

DCM Shriram LtdQ4 FY23Diversified

DCM Shriram Ltd Q4 FY23 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹1,002.05P/E: 11.4Market Cap: ₹15.6K CrSector: Diversified

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

N/A

Order

Yes

Capex

Yes

2 of 4 growth signals are positive.

Full analysis

Revenue guidance

Category 3

Bioseed business: Expected to grow in FY24 at least at the same rate as FY23, driven by market-accepted products and a robust pipeline across all key crops (cotton, corn, paddy, vegetables). Long-term growth positive but dependent on competitive landscape yearly. (Pages 16-17)
Ethanol production capacity expanding from 14 crore liters to 18 crore liters in the coming year, indicating higher sales volumes. (Pages 5, 10, 14)
Fenesta Building Systems: Strong order book growth (~10-23%) and volume increases in projects and retail, indicating sustained revenue growth. (Pages 6-7)
Chemicals business: Moderate global demand but domestic capacity utilization stable (~89%). Prices soft but no major global capacity additions foreseen, supporting balanced medium-term growth. (Page 3)
Sugar business: Revenues up 21-24% due to higher volumes and better prices; crushing expected at ~650 lakh quintals compared to 549 last season. (Pages 6-7)
Fertilizer: Volume growth (+4% YoY) expected; revenue down slightly due to gas price pass-through but overall PBDIT growing (44%). (Page 7)
Overall company: Focus on scale, product diversification, efficiency, and new product lines to drive growth. (Pages 3, 5, 16-17)

Margin guidance

Category 3

Bioseed business is expected to grow in FY24 at similar or better rates than FY23 due to accepted products and a strong pipeline across crops like cotton, corn, paddy, and vegetables. Long-term growth over the next 3-4 years is anticipated but subject to market competition.
Chemicals segment margins are expected to improve gradually with declining input costs and completion of capacity expansions by Q2 FY24, though price volatility in epoxy and ECH may impact near-term spreads.
Fertilizer segment sees improved energy efficiencies and subsidy reductions aiding profitability despite price corrections.
Fenesta building systems anticipate good growth driven by project segment volume increase and expanded product offerings.
Overall company strategy focuses on growing economies of scale, new product lines, efficiency, innovation, circular economy, and sustainability to deliver better earnings and growth.
Return on capital employed for FY23 was strong at 27%, with committed efforts to maintain a solid financial position and explore new growth avenues.

See what DCM Shriram Ltd management said on margin guidance — free account, 30 seconds.

Fundraise plans

The company has ongoing CAPEX plans with a remaining Rs. 1,500 crore to be spent in FY24.
Peak net debt by March is expected to be in the range of Rs. 1,500 to Rs. 1,900 crore.
No specific mention of new fundraising through equity or fresh debt in the disclosed content.
Existing debt levels are comfortable with net debt at Rs. 681 crore as of 31st March 2023.
Management is focusing on maintaining a strong financial position and exploring new avenues for growth, but no explicit plans for fundraising were detailed.

Order book

Yes

Fenesta Building Systems' order book grew by 10% year-on-year.
The project and retail categories both witnessed improvements in the order book.
The demand scenario for Fenesta is stable, although competition is increasing.
The company is expanding its core business, adding new categories and increasing geographic reach, including internationally.
New products such as glass façades, UPVC and aluminum windows, WPC, and engineered wood doors are being launched.
Two new factories commissioned (Bhuvneshwar and Hyderabad), with expansion underway at Kota.
Overall, the order book reflects good momentum quarter-on-quarter, driven by project segment growth.

See what DCM Shriram Ltd management said on order book — free account, 30 seconds.

Capex plans

Yes

Total CAPEX program is Rs. 3,500 crore, with about Rs. 600 crore already commissioned (Rs. 530 crore in sugar, Rs. 60-70 crore in chemicals).
Remaining Rs. 2,900 crore largely in chemicals to be commissioned over next two quarters (by end of Q2 FY24).
120 MW power plant project costing Rs. 500-550 crore expected to be commissioned by Q1 end FY24, providing annual savings of Rs. 100-125 crore.
Rs. 530 crore sugar CAPEX already capitalized with expected ~20% return.
Facilities and expansions in Fenesta (Bhuvneshwar, Hyderabad, Kota) ongoing to meet rising demand.
New product lines and manufacturing expansions in Shriram Farm Solutions, including crop protection chemicals, water-soluble fertilizers, and biologicals, with manufacturing starting in FY24 Q4.
Sustainability-related CAPEX includes green power projects like 50 MW Hybrid Green Power and biomass usage increase.
Focus on circular economy, energy efficiency, and waste reduction ongoing through projects like K2SO4 Fertilizer and sodium sulfate production.

Track DCM Shriram Ltd — get its next earnings analysis in your feed

How does DCM Shriram Ltd rank vs peers in Diversified?

Pro feature

ThisDCM Shriram Ltd

Rev 3Mar 3

See where DCM Shriram Ltd sits in DiversifiedSee which companies these are, and every other name in the sector.Open rankings

How does DCM Shriram Ltd rank in Diversified?

Compare DCM Shriram Ltd against every Diversified company (Q4 FY23) on revenue, margins and earnings-call signals.

View Diversified leaderboard →

What DCM Shriram Ltd's management said in earlier quarters

Others in Diversified this season

Godrej Industries Ltd (Q4 FY25)
Q4 FY 2024-25 Total Income (Consolidated): ₹6,400 crore, up 25% YoY from ₹5,103 crore (Page 6). Key concall takeaways from Godrej Industries Ltd's Q4 FY25…
Godrej Industries Ltd (Q1 FY26)
Consolidated Total Income: ₹5,719 crore in Q1 FY26, up 9% YoY from ₹5,259 crore in Q1 FY25. Key concall takeaways from Godrej Industries Ltd's Q1 FY26 earnings…
Godrej Industries Ltd (Q2 FY26)
Consolidated Total Income:** ₹6,290 crore, up 23% YoY (Page 6) . Key concall takeaways from Godrej Industries Ltd's Q2 FY26 earnings call — and how it ranks…
Godrej Industries Ltd (Q3 FY26)
Consolidated sales revenue grew by 9% YoY in INR. Key concall takeaways from Godrej Industries Ltd's Q3 FY26 earnings call — and how it ranks against sector…

Compare:vs Godrej Industries Ltd vs 3M India Ltd vs TTK Healthcare

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

DCM Shriram Ltd Q4 FY23 Earnings Call Analysis

Revenue guidance

Fundraise plans

Capex plans

How does DCM Shriram Ltd rank in Diversified?

Continue your research

What DCM Shriram Ltd's management said in earlier quarters

Others in Diversified this season